Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
16.93
0.07 (0.42%)
At close: Aug 15, 2025, 3:59 PM
16.95
0.12%
After-hours: Aug 15, 2025, 07:36 PM EDT
Spyre Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -36.72M | -44.77M | -56.3M | -69.03M | -38.84M | -43.86M | -63.18M | -40.11M | -217.08M | -18.42M | -18.82M | -18.23M | -22.32M | -24.44M | -20.45M | -20.31M | -6.83M | -18.22M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | -220K | n/a | 580K | 384K | 490K | 502K | 475K | 497K | 502K | 527K | 509K | 355K |
Stock-Based Compensation | 9.38M | 8.86M | 9.22M | 13.1M | 8.68M | 13.84M | 17.27M | 4.79M | 1.91M | 1.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.76M |
Other Working Capital | n/a | -3.59M | 31.28M | 23.75M | -35.79M | 7.77M | -1.08M | -6.91M | 5.31M | -2.75M | 1.9M | -1.08M | -53K | -4.07M | -2.97M | 830K | -15.43M | 18.34M |
Other Non-Cash Items | -19.22M | -4.51M | -917K | 824K | -887K | 16.14M | 18.66M | 8.68M | -160K | 166K | 5.83M | 326K | 4.21M | 3.42M | 1.74M | 3.67M | 2.71M | 115K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.71M | n/a | 192.13M | -107K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -568K | 10.8M | 25.68M | -29.16M | 3.47M | -1.86M | -7.95M | 5.97M | -1.36M | -1.16M | 1.13M | -1.07M | -4.41M | -1.51M | 495K | 6.39M | -3.54M |
Operating Cash Flow | -46.56M | -40.99M | -37.2M | -29.42M | -62.25M | -28.54M | -31.04M | -34.6M | -16.64M | -17.63M | -18.14M | -15.07M | -20.67M | -26.26M | -19.27M | -17M | 2.08M | -19.53M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | -37K | n/a | -93K | -30K | -450K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -15.47M | 15M | 475K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -34.87M | -71.44M | -233.09M | -35.05M | -178.39M | -152.71M | -54.17M | -112.63M | n/a | n/a | -4.5M | -7.25M | -24.25M | -3.5M | -13.25M | -26.25M | -69.33M | -24.25M |
Sales Maturities Of Investments | 106.87M | 71.38M | 62.55M | 77.79M | 57.88M | 47.75M | 18.9M | n/a | 3.25M | 17.75M | 18.5M | 23.75M | 25M | 29.3M | 22.91M | 32.12M | 22M | 34M |
Other Investing Acitivies | 7M | n/a | n/a | n/a | n/a | n/a | 15.47M | n/a | 3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 79M | -61K | -170.54M | 42.74M | -120.52M | -104.96M | -35.27M | -97.63M | 6.76M | 17.75M | 14M | 16.5M | 750K | 25.76M | 9.66M | 5.78M | -47.36M | 9.3M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8K | -8K | -8K | -63K | -175K | -172K | -169K | -108K | -228K | -5K |
Common Stock Repurchased | n/a | -117K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 731K | 125K | -329K | 1.24M | 169.56M | 2.96M | -5.79M | n/a | n/a | 18K | n/a | n/a | 42.98M | 184K | 249K | 1.25M | n/a | 367K |
Financial Cash Flow | 731K | 125K | 225.6M | 12.78M | 360K | 172.16M | 163.61M | -12.53M | 209.99M | 10K | -8K | -130K | 42.8M | 12K | 80K | 1.14M | -192K | 362K |
Net Cash Flow | 33.17M | -40.93M | 17.84M | 26.44M | -182.41M | 38.66M | 97.32M | -144.78M | 200.12M | 137K | -4.13M | 1.52M | 22.83M | -505K | -9.52M | -10.08M | -45.47M | -9.86M |
Free Cash Flow | -46.56M | -40.99M | -37.2M | -29.42M | -62.25M | -28.54M | -31.04M | -34.6M | -16.64M | -17.63M | -18.14M | -15.07M | -20.67M | -26.3M | -19.27M | -17.09M | 2.05M | -19.98M |